Epimède logo

Epimède

Europe, Liege, Belgium, Liège

Description

Epimède provides and offers funding assistance to technological businesses.

Investor Profile

Epimède has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series D rounds (top funding stages).
  • Majority of deals are located in Belgium, The Netherlands.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (40%)
  • Series Unknown (20%)
  • Series D (20%)
  • Series C (20%)

Country Focus

  • Belgium (80%)
  • The Netherlands (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device
  • Therapeutics
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Epimède frequently co-invest with?

Pfizer
North America, New York, United States, New York
Co-Investments: 1
Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 1
B
Europe, Liege, Belgium, Liège
Co-Investments: 1
CI
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Co-Investments: 1
White Fund
Europe, Liege, Belgium, Liège
Co-Investments: 1
KU Leuven
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Capricorn Partners
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 3
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 4

What are some of recent deals done by Epimède?

Imcyse

Liège, Liege, Belgium

Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.

BiotechnologyPharmaceuticalTherapeutics
Series BFeb 17, 2021
Amount Raised: $25,659,559
Endo Tools Therapeutics

Gosselies, Hainaut, Belgium

Endo Tools Therapeutics develops medical devices that provide new means of therapeutic interventions for gastroenterologists.

Health CareMedicalMedical Device
Series DJan 19, 2021
Amount Raised: $9,711,661
Endo Tools Therapeutics

Gosselies, Hainaut, Belgium

Endo Tools Therapeutics develops medical devices that provide new means of therapeutic interventions for gastroenterologists.

Health CareMedicalMedical Device
Series CFeb 11, 2019
Amount Raised: $5,639,331
Ncardia

Leiden, Zuid-Holland, The Netherlands

Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.

BiotechnologyHealth CareMedicalPharmaceutical
Series BNov 17, 2017
Amount Raised: $12,380,543
Diagenode

Liège, Liege, Belgium

Diagenode is a company providing solutions in biological sample preparation and more.

BiotechnologyHealth DiagnosticsLife Science
Series UnknownJun 20, 2016
Amount Raised: $8,487,014